9238
L. Hao et al. / Tetrahedron 68 (2012) 9234e9239
(CDCl3, 100 MHz, ppm)
d
¼162.86, 162.47, 161.96, 161.59, 149.25,
triflic acid (0.25 mL) was stirred at 110 ꢀC until the starting material
could not be detected by TLC. Then the reaction mixture was cooled
to room temperature and diluted with water, alkalized with 15%
aqueous NaOH solution and extracted with CH2Cl2 (20 mL). The
organic phase was washed with brine and water, and dried with
Na2SO4. The crude product was purified by silica gel column
chromatography (CH2Cl2/PE¼1:1 in v/v) to afford 8 and 80 (150 mg,
30%, the ratio of 8 to 80 is 2:1) as yellow solids. Then the mixture
isomers were recrystallized with CH2Cl2 and hexane and the
regioisomerically pure 8 was obtained.
148.88, 145.90, 145.82, 145.75, 133.58, 132.05, 131.11, 130.69, 130.52,
130.34, 130.16, 130.07, 129.84, 129.74, 129.54, 129.48, 129.38, 128.60,
128.36, 128.24, 127.22, 127.07, 126.33, 125.85, 124.95, 124.76, 124.67,
124.58, 123.96, 29.75, 29.68, 29.61, 24.36. MS (MALDI-TOF): calcd
for Mꢁ, 800.3; found, 800.4.
4.3. Synthesis of amino-PBIs (4 or 7)
To a solution of 1-nitro-PBI 2 or 1,7-dinitro-PBI 3 (0.25 mmol) in
1,2-dimethoxyethane (10 mL) was added about 10% palladium on
charcoal (20 mg), then 0.2 mL of 85% hydrazine wad added into the
reaction. The mixture was stirred at 83 ꢀC for 15 min, and then
cooled to room temperature. The catalyst was removed and the
solvent was distilled to leave a blue solid. The crude product either
monoamino-PBI 4 or diamino-PBI 7 was used directly for the next
step without further purification because of the instability of the
amino in the air.
Compound 8: 1H NMR (CDCl3, 400 MHz, ppm)
d
¼10.41 (s, 2H),
10.30 (s, 2H), 8.27 (d, J¼8.0 Hz, 4H), 7.75e7.85 (m, 6H), 7.56e7.59
(m, 2H), 7.43e7.45 (m, 4H), 2.95e2.97 (m, 4H), 1.24e1.26 (m, 24H).
13C NMR (C2D2Cl4, 100 MHz, ppm)
d
¼163.90, 163.75, 162.72, 145.43,
143.14, 138.13, 134.36, 131.13, 130.88, 130.58, 130.30, 129.68, 129.25,
127.51, 125.15, 124.47, 124.22, 123.23, 122.47, 120.09, 118.37, 31.48,
29.26, 24.14, 22.60. MS (MALDI-TOF): calcd for Mꢁ, 912.4; found,
912.7. HRMS calcd for C62H49N4Oþ4 [MHþ], 913.37483; found,
913.37329.
4.4. Synthesis of N-decorated PBIs and CBIs
Compound 80: 1H NMR (CDCl3, 400 MHz, ppm)
d
¼10.39 (s, 2H),
10.35 (s, 2H), 8.25 (s, 2H), 8.26 (s, 2H), 7.75e7.85 (m, 6H), 7.54e7.60
(m, 2H), 7.41e7.46 (m, 4H), 2.87e3.04 (m, 4H), 1.21e1.27 (m, 24H).
MS (MALDI-TOF): calcd for Mꢁ, 912.4; found, 912.7.
4.4.1. Compound (5). A mixture of monoamino-PBI 4 (200 mg) and
benzaldehyde (175 mg, 1.65 mmol) in DMF (10 mL) containing
triflic acid (0.1 mL) was stirred at 110 ꢀC until the starting material
could not be detected by TLC. Then the reaction mixture was cooled
to room temperature and diluted with water, alkalized with 15%
aqueous NaOH solution and extracted with CH2Cl2 (20 mL). The
organic phase was washed with brine and water, and dried with
Na2SO4. The crude product was purified by silica gel column
chromatography (CH2Cl2/PE¼1:1 in v/v) to afford 5 (94 mg, 42.1%)
4.4.4. Compound (90). A mixture of diamino-PBI 7 (300 mg) and 2-
pyridinecarboxaldehyde (520 mg, 4.86 mmol) in DMF (15 mL)
containing triflic acid (0.15 mL) was stirred at 110 ꢀC until the
starting material could not be detected by TLC. Then the reaction
mixture was cooled to room temperature and diluted with water,
alkalized with 15% aqueous NaOH solution and extracted with
CH2Cl2 (20 mL). The organic phase was washed with brine and
water, and dried with Na2SO4. The crude product was purified by
silica gel column chromatography (CH2Cl2/THF¼150:1 in v/v) to
afford 90 (102 mg, 27.7%) as yellow solid. 1H NMR (CDCl3, 400 MHz,
as an orange-yellow solid. 1H NMR (CDCl3, 400 MHz, ppm)
d¼9.81
(s, 1H), 9.75 (s, 1H), 9.51 (d, J¼8.0 Hz, 2H), 9.31 (d, J¼8.0 Hz, 1H),
9.26 (d, J¼8.0 Hz, 1H), 8.05 (d, J¼8.0 Hz, 2H), 7.66e7.75 (m, 3H),
7.51e7.56 (m, 2H), 7.37e7.41 (m, 4H), 2.79e2.91 (m, 4H), 1.20e1.24
(m, 24H). 13C NMR (THF-d8, 100 MHz, ppm)
d¼164.42, 164.12,
ppm)
d
¼11.12 (s, 2H), 10.36 (s, 2H), 9.11e9.12 (m, 2H), 8.79e8.81 (d,
164.00, 162.01, 146.91, 146.83, 145.41, 139.58, 135.63, 135.54, 134.20,
133.13, 132.20, 132.11, 132.03, 131.65, 130.49, 130.33, 130.05, 129.61,
129.49, 127.96, 127.21, 125.82, 125.02, 124.93, 124.58, 124.53, 124.36,
124.30, 124.20, 123.30, 122.69, 119.56, 30.16, 30.09, 24.50, 24.40. MS
(MALDI-TOF): calcd for Mꢁ, 811.3; found, 811.3. HRMS calcd for
C55H46N3Oþ4 [MHþ], 812.34828; found, 812.34618.
J¼8.0 Hz, 2H), 8.25e8.29 (m, 2H), 7.71e7.74 (m, 2H), 7.55e7.62 (m,
2H), 7.42e7.48 (m, 4H), 2.92e3.06 (m, 4H), 1.23e1.28 (m, 24H). 13C
NMR (CDCl3, 100 MHz, ppm)
d
¼164.12, 164.02, 163.93, 157.95,
157.49, 149.52, 146.03, 144.49, 138.17, 136.01, 135.10, 134.98, 133.90,
131.83, 130.88, 130.85, 130.60, 130.48, 130.21, 130.09, 129.36, 129.15,
128.55,127.73,126.59,126.30,125.62,124.69,124.59, 124.50, 124.27,
124.10, 123.94, 123.63, 123.47, 122.80, 122.70, 120.17, 29.70, 29.62,
24.50, 24.41. MS (MALDI-TOF): calcd for Mꢁ, 914.4; found, 914.2.
HRMS calcd for C60H47N6Oþ4 [MHþ], 915.36533; found, 915.36287.
4.4.2. Compound (6). A mixture of monoamino-PBI 4 (200 mg) and
2-pyridinecarboxaldehyde (180 mg, 1.68 mmol) in DMF (10 mL)
containing triflic acid (0.15 mL) was stirred at 110 ꢀC until the
starting material could not be detected by TLC. Then the reaction
mixture was cooled to room temperature and diluted with water,
alkalized with 15% aqueous NaOH solution and extracted with
CH2Cl2 (20 mL). The organic phase was washed with brine and
water, and dried with Na2SO4. The crude product was purified by
silica gel column chromatography (CH2Cl2/PE¼1:1 in v/v) to afford
6 (83 mg, 37.4%) as an orange-yellow solid. 1H NMR (CDCl3,
Acknowledgements
For financial support of this research, we thank the National
Natural Science Foundation of China (91027043, 21190032), 973
Program (Grant 2011CB932301), Chinese Academy of Sciences. We
are grateful to Prof. J. Pei (Peking University) for his profound
discussions.
400 MHz, ppm)
d
¼10.47 (s, 1H), 9.79 (s, 1H), 9.51 (dd, 2H), 9.31 (dd,
2H), 8.99 (d, J¼8.0 Hz, 1H), 8.58 (d, J¼8.0 Hz, 1H), 8.12e8.16 (m, 1H),
7.57e7.62 (m, 1H), 7.51e7.55 (m, 2H), 7.38e7.42 (m, 4H), 2.81e2.92
(m, 4H), 1.20e1.24 (m, 24H). 13C NMR (CDCl3, 100 MHz, ppm)
Supplementary data
1H and 13C spectra for all the new compounds. Supplementary
d
¼164.13, 164.04, 164.01, 163.95, 157.89, 157.44, 149.48, 146.04,
144.52, 138.23, 136.03, 135.13, 134.95, 133.93, 131.86, 130.88, 130.62,
130.51, 130.21, 130.09, 129.17, 127.76, 126.61, 126.32, 124.72, 124.59,
124.50, 124.30, 124.13, 123.97, 123.66, 123.49, 122.82, 122.72, 120.21,
29.70, 29.63, 24.49, 24.41. MS (MALDI-TOF): calcd for Mꢁ, 812.3;
found, 812.4. HRMS calcd for C54H45N4Oþ4 [MHþ], 813.34353; found,
813.34306.
References and notes
1. (a) Huang, C.; Barlow, S.; Marder, S. R. J. Org. Chem. 2011, 76, 2386; (b) Dittmer,
J. J.; Marseglia, E. A.; Friend, R. H. Adv. Mater. (Weinheim, Ger.) 2000, 12, 1270; (c)
Zhan, X.; Tan, Z.; Domercq, B.; An, Z.; Zhang, X.; Barlow, S.; Li, Y.; Zhu, D.;
Kippelen, B.; Marder, S. R. J. Am. Chem. Soc. 2007, 129, 7246; (d) Li, J.; Dierschke,
4.4.3. Compound (8 and 80). A mixture of diamino-PBI 7 (400 mg)
and benzaldehyde (696 mg, 6.56 mmol) in DMF (20 mL) containing
€
F.; Wu, J.; Grimsdale, A. C.; Mullen, K. J. Mater. Chem. 2006, 16, 96.